Cypress Bioscience, Inc.
Patent Owner
Stats
- 4 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- Apr 07, 2015 most recent publication
Details
- 4 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 513 Total Citation Count
- Jan 11, 1985 Earliest Filing
- 34 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
| Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
7915246 Methods of treating fibromyalgia syndrome, chronic fatigue syndrome and painFeb 22, 08Mar 29, 11[A61K]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2010/0240,541 GENETIC MARKERS FOR PROGNOSIS OF ANTIFOLATE TREATMENT EFFICACYAbandonedMar 29, 10Sep 23, 10[C12Q, C40B]
2010/0160,294 TOLERABILITY OF MIRTAZAPINE AND A SECOND ACTIVE BY USING THEM IN COMBINATIONAbandonedDec 14, 09Jun 24, 10[A61K, A61P]
2010/0105,778 METHODS OF TREATING FIBROMYALGIA SYNDROME, CHRONIC FATIGUE SYNDROME AND PAINAbandonedDec 28, 09Apr 29, 10[A61K, A61P]
2010/0105,779 METHODS OF TREATING FIBROMYALGIA SYNDROME, CHRONIC FATIGUE SYNDROME AND PAINAbandonedDec 28, 09Apr 29, 10[A61K, A61P]
2010/0081,719 MILNACIPRAN FOR THE TREATMENT OF FATIGUE ASSOCIATED WITH FIBROMYALGIA SYNDROMEAbandonedDec 03, 09Apr 01, 10[A61K, A61P]
2009/0197,268 METHODS FOR OPTIMIZING CLINICAL RESPONSIVENESS TO METHOTREXATE THERAPY USING METABOLITE PROFILING AND PHARMACOGENETICSAbandonedAug 13, 08Aug 06, 09[C12Q]
2009/0105,222 PREVENTION AND TREATMENT OF FUNCTIONAL SOMATIC DISORDERS, INCLUDING STRESS-RELATED DISORDERSAbandonedSep 19, 08Apr 23, 09[A61K]
2009/0048,233 Enhancing the Tolerability of a Seratonin Antagonist and a NSRI, a SNRI or a RIMA by Using Them in CombinationAbandonedAug 15, 08Feb 19, 09[A61K, A61P]
2008/0293,820 METHODS FOR IMPROVING PHYSICAL FUNCTION IN FIBROMYALGIAAbandonedMay 22, 08Nov 27, 08[A61K]
2008/0268,045 SUSTAINED RELEASE METHOTREXATE FORMULATIONS AND METHODS OF USE THEREOFAbandonedNov 09, 07Oct 30, 08[A61K, A61P]
2008/0058,317 MILNACIPRAN FOR THE TREATMENT OF FATIGUE ASSOCIATED WITH FIBROMYALGIA SYNDROMEAbandonedAug 08, 07Mar 06, 08[A61K, A61P]
2008/0058,318 MILNACIPRAN FOR THE TREATMENT OF COGNITIVE DYSFUNCTION ASSOCIATED WITH FIBROMYALGIAAbandonedAug 08, 07Mar 06, 08[A61K, A61P]
2007/0225,258 COMPOSITIONS COMPRISING BISPHOSPHONATE AND AN ANTIFOLATEAbandonedFeb 02, 07Sep 27, 07[A61K]
2007/0225,375 METHODS OF TREATING FIBROMYALGIA SYNDROME, CHRONIC FATIGUE SYNDROME AND PAINAbandonedMay 22, 07Sep 27, 07[A61K]
2007/0123,555 PREVENTION AND TREATMENT OF HEARING DISORDERSAbandonedSep 28, 06May 31, 07[A61K, A01N]
2006/0122,127 Methods for reducing the side effects associated with mirtzapine treatmentAbandonedNov 17, 05Jun 08, 06[A61K]
2006/0039,866 Method for treating sleep-related breathing disordersAbandonedAug 19, 05Feb 23, 06[A61K, A61L]
2006/0039,867 Method for treating sleep-related breathing disorders with setiptilineAbandonedAug 19, 05Feb 23, 06[A61K, A61L]
Top Inventors for This Owner
| Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.